1. Home
  2. KALA vs WAI Comparison

KALA vs WAI Comparison

Compare KALA & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • WAI
  • Stock Information
  • Founded
  • KALA 2009
  • WAI 2018
  • Country
  • KALA United States
  • WAI China
  • Employees
  • KALA N/A
  • WAI 85
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • WAI
  • Sector
  • KALA Health Care
  • WAI
  • Exchange
  • KALA Nasdaq
  • WAI NYSE
  • Market Cap
  • KALA 26.2M
  • WAI 5.5M
  • IPO Year
  • KALA 2017
  • WAI 2023
  • Fundamental
  • Price
  • KALA $5.70
  • WAI $0.43
  • Analyst Decision
  • KALA Strong Buy
  • WAI
  • Analyst Count
  • KALA 3
  • WAI 0
  • Target Price
  • KALA $14.00
  • WAI N/A
  • AVG Volume (30 Days)
  • KALA 137.4K
  • WAI 1.9M
  • Earning Date
  • KALA 08-05-2025
  • WAI 08-24-2025
  • Dividend Yield
  • KALA N/A
  • WAI N/A
  • EPS Growth
  • KALA N/A
  • WAI N/A
  • EPS
  • KALA N/A
  • WAI N/A
  • Revenue
  • KALA N/A
  • WAI $3,750,352.00
  • Revenue This Year
  • KALA N/A
  • WAI N/A
  • Revenue Next Year
  • KALA N/A
  • WAI N/A
  • P/E Ratio
  • KALA N/A
  • WAI N/A
  • Revenue Growth
  • KALA N/A
  • WAI N/A
  • 52 Week Low
  • KALA $2.92
  • WAI $0.41
  • 52 Week High
  • KALA $11.20
  • WAI $20.00
  • Technical
  • Relative Strength Index (RSI)
  • KALA 59.39
  • WAI N/A
  • Support Level
  • KALA $5.39
  • WAI N/A
  • Resistance Level
  • KALA $6.30
  • WAI N/A
  • Average True Range (ATR)
  • KALA 0.63
  • WAI 0.00
  • MACD
  • KALA 0.03
  • WAI 0.00
  • Stochastic Oscillator
  • KALA 56.00
  • WAI 0.00

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About WAI TOP KINGWIN LTD

Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).

Share on Social Networks: